Wireless accelerometer configuration for monitoring Parkinson’s disease hand tremor ,APD,Vol.2 No.2, 2013
Robert LeMoyne Timothy Mastroianni Warren Grundfest
Citations: 52(Details)

The effects of a supervised Pilates training program on balance in Parkinson’s disease ,APD,Vol.2 No.2, 2013
Liam Johnson David Putrino Ian James Julian Rodrigues Rick Stell Gary Thickbroom Frank L. Mastaglia
Citations: 41(Details)

Curcumin protects against rotenone-induced neurotoxicity in cell and drosophila models of Parkinson’s disease ,APD,Vol.2 No.1, 2013
Zhaohui Liu Tianxia Li Dejun Yang Wanli W. Smith
Citations: 33(Details)

Wearable and wireless accelerometer systems for monitoring Parkinson’s disease patients—A perspective review ,APD,Vol.2 No.4, 2013
Robert LeMoyne
Citations: 29(Details)

Biological sources of L-DOPA: An alternative approach ,APD,Vol.2 No.3, 2013
Sushama A. Patil Onkar A. Apine Shripad N. Surwase Jyoti P. Jadhav
Citations: 24(Details)

Pragmatic language production deficits in Parkinson’s disease ,APD,Vol.2 No.1, 2013
Thomas Holtgraves Kelly Fogle Lindsay Marsh
Citations: 21(Details)

Virtual games and quality of life in Parkinson’s disease: A randomised controlled trial ,APD,Vol.2 No.4, 2013
Glicia Pedreira Antonio Prazeres Danilo Cruz Irênio Gomes Larissa Monteiro Ailton Melo
Citations: 18(Details)

Aquatic physical therapy for Parkinson’s disease ,APD,Vol.2 No.4, 2013
Talita Gianello Gnoato Zotz Eliani Arruda Souza Vera Lúcia Israel Ana Paula Cunha Loureiro
Citations: 16(Details)

Implementation of a Smartphone as a Wearable and Wireless Accelerometer and Gyroscope Platform for Ascertaining Deep Brain Stimulation Treatment Efficacy of Parkinson’s Disease through Machine Learning Classification ,APD,Vol.7 No.2, 2018
Robert LeMoyne Timothy Mastroianni Cyrus McCandless Christopher Currivan Donald Whiting Nestor Tomycz
Citations: 15(Details)

Comparison of the Analgesic Activity of Antiparkinsonian Aminoadamantane Derivatives Amantadine and Hemantane ,APD,Vol.5 No.3, 2016
Elena Ivanova Inga Kapitsa Elena Valdman Tatyana Voronina
Citations: 14(Details)

The Development of Treatment for Parkinson’s Disease ,APD,Vol.4 No.3, 2015
Harishankar Prasad Yadav Yun Li
Citations: 13(Details)

Tai Chi in Parkinson’s Disease: A Preliminary Randomized, Controlled, and Rater-Blinded Study ,APD,Vol.4 No.1, 2015
Roger Kurlan Roye Evans Sandra Wrigley Shannon McPartland Rami Bustami Ann Cotter
Citations: 12(Details)

Should gait speed be included in the clinical evaluation of Parkinson’s disease? ,APD,Vol.1 No.1, 2012
Joe Nocera Chris Hass
Citations: 10(Details)

Racial Disparities in Parkinson Disease: A Systematic Review of the Literature ,APD,Vol.5 No.4, 2016
Chantale O. Branson Andrew Ferree Anna D. Hohler Marie-Helene Saint-Hilaire
Citations: 8(Details)

The International Classification of Functioning, Disability and Health as Applied to Parkinson’s Disease: A Literature Review ,APD,Vol.5 No.2, 2016
Audrin Said Vojciechowski Talita Gianello Gnoato Zotz Ana Paula Cunha Loureiro Vera Lúcia Israel
Citations: 7(Details)

Parkinson’s Disease Treatment as Seen from a Mechanical Point of View ,APD,Vol.5 No.4, 2016
Sarah Gebai Mohamad Hammoud
Citations: 6(Details)

Potential of a planarian model to study certain aspects of anti-Parkinsonism drugs ,APD,Vol.2 No.3, 2013
Robert B. Raffa Jeff Danah Christopher S. Tallarida Carrie Zimmerman Grace Gill Steven J. Baron Scott M. Rawls
Citations: 6(Details)

Effect of Abnormal Posture on Quality of Life in Patients with Parkinson’s Disease ,APD,Vol.5 No.2, 2016
Kyohei Mikami Makoto Shiraishi Tsutomu Kamo
Citations: 5(Details)

Effectiveness of Istradefylline for Fatigue and Quality of Life in Parkinson’s Disease Patients’ and of Their Caregivers’ ,APD,Vol.5 No.2, 2016
Kazuo Abe 1 1 Masashi Fujita Hiroo Yoshikawa
Citations: 5(Details)

Properties of the Apathy Scale (AS) for use on Parkinson’s patients ,APD,Vol.2 No.2, 2013
Marcos Serrano-Dueñas Pablo Martínez-Martín Tamara Merchán Rosaura Bravo Maite Serrano
Citations: 5(Details)

Pseudoparkinsonism: A review of a common nonparkinsonian hypokinetic movement disorder ,APD,Vol.2 No.4, 2013
Roger Kurlan Marcie L. Rabin
Citations: 5(Details)

The Application of Palliative Care Principles in Advanced Parkinson’s Disease ,APD,Vol.5 No.4, 2016
Sunjay Sethi Anna DePold Hohler
Citations: 4(Details)

Medical Food to Stop the Progression of Parkinson’s Disease ,APD,Vol.3 No.2, 2014
Don McCammon
Citations: 4(Details)

A Brief Clinical Assessment of Cognitive Deficit with Impaired Daily Living Functioning in Parkinson’s Patients with and without Dementia ,APD,Vol.5 No.2, 2016
Sadaf Naeem Rahila Najam Nausheen Alam Syed Waseem Akhter
Citations: 4(Details)

Planning a Patient-Centered Parkinson’s Disease Support Program: Insights from Narrative Medicine ,APD,Vol.3 No.4, 2014
Nancy Gross Melissa Nicolas Susan Neigher Shannon McPartland Melvyn Heyes Sandra Wrigley Roger Kurlan
Citations: 4(Details)

Efficacy of rehabilitation program in addition to pharmacological treatment during 8 months in Parkinson patients ,APD,Vol.1 No.2, 2012
Jesús Seco Calvo Inés Gago Fernández Juan Azael Herrero Alonso Javier González Gallego Nuria Garatachea Vallejo
Citations: 4(Details)

Frequency of Low Vitamin D3 Levels in Subjects with Parkinson’s Disease. A Study Conducted at PMCH, a Tertiary Care Hospital, Nawabshah ,APD,Vol.7 No.1, 2018
Anwar Ali Jamali Ghulam Mustafa Jamali Bhojo Mal Tanwani Niaz Hussain Jamali Moti Ram Bhatia
Citations: 4(Details)

Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying? ,APD,Vol.6 No.1, 2017
Maria Nord Anita Kullman Ulf Hannestad Nil Dizdar
Citations: 4(Details)

A prescription for physical therapy and exercise in Parkinson’s disease ,APD,Vol.2 No.4, 2013
Marie Saint-Hilaire Theresa Ellis
Citations: 4(Details)

Parkinson’s disease: Is there a light at the end of a tunnel? ,APD,Vol.2 No.4, 2013
Andrei Surguchov
Citations: 3(Details)

The Cardiovascular and Cerebrovascular Effects on Cognition in Persons with Parkinson’s Disease: A Systematic Review of the Literature ,APD,Vol.4 No.2, 2015
Adrianna Carey Rebecca Julian Katlyn Kristeller Peter Leonard Sara Palmer Laura Krisa
Citations: 3(Details)

Lack of Association between Impulse Control Disorders and REM Sleep Behavior Disorder in Patients with Parkinson’s Disease ,APD,Vol.5 No.4, 2016
Lisette Bazán-Rodríguez Mayela Rodríguez-Violante Amin Cervantes-Arriaga Guillermo Parra-López Diego Cruz-Fino Francisco Pascasio-Astudillo Vanessa Alatriste-Booth 1 1
Citations: 3(Details)

The Effects of Exercise on People with Parkinson’s Disease—Review ,APD,Vol.6 No.1, 2017
Iva Musulin
Citations: 3(Details)

Factors affecting early decline of executive function after subthalamic nucleus stimulation in Parkinson’s disease ,APD,Vol.2 No.3, 2013
Atsushi Umemura Yuichi Oka Rika Tsuboi Sonoko Fujii Yoko Shimizu Kenji Okita Noriyuki Matsukawa Kazuo Yamada
Citations: 2(Details)

Evaluation of Clinical Utility of the Personal KinetiGraph^® in the Management of Parkinson Disease ,APD,Vol.8 No.3, 2019
Fatta B. Nahab Hamad Abu-Hussain Lissette Moreno
Citations: 2(Details)

Resistance Training in Parkinson’s Disease: A Longitudinal Study ,APD,Vol.6 No.2, 2017
Luca Beratto Federico Abate Daga Ruben Allois Massimiliano Gollin
Citations: 2(Details)

Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson’s Disease ,APD,Vol.6 No.2, 2017
Maria Nord Peter Zsigmond Anita Kullman Nil Dizdar
Citations: 2(Details)

Five-Year Outcomes of Bilateral Subthalamic Nucleus Stimulation in Japanese Patients with Parkinson’s Disease ,APD,Vol.4 No.2, 2015
Atsushi Umemura Miwako Miyata Yuichi Oka Kenji Okita Genko Oyama Yasushi Shimo Nobutaka Hattori
Citations: 2(Details)

Preliminary evidence of discourse improvement with dopaminergic medication ,APD,Vol.2 No.2, 2013
Janelle Sanchez Kristie A. Spencer
Citations: 2(Details)

Pink1 and parkin demonstrate multifaceted roles when co-expressed with Foxo ,APD,Vol.2 No.1, 2013
Amy M. Todd Brian E. Staveley
Citations: 2(Details)

The activity of antiparkinsonian drug hemantane in models of peripheral inflammation and lipopolysaccharide-induced neuroinflammation ,APD,Vol.2 No.1, 2013
Elena Ivanova Inga Kapitsa Elena Valdman Tatyana Voronina
Citations: 2(Details)

Quantitative EEG Changes in Patients with Parkinson’s Disease during Therapy with Rasagiline ,APD,Vol.3 No.3, 2014
Wilfried Dimpfel Christian Oehlwein Josef Anton Hoffmann Thomas Müller
Citations: 2(Details)

On Heredity Factors of Parkinson’s Disease: A Parametric and Bayesian Analysis ,APD,Vol.7 No.3, 2018
Abolfazl Saghafi Chris P. Tsokos Rebecca D. Wooten
Citations: 1(Details)

Comparison of continuous versus pulsatile dopaminergic therapy in the erderly with Parkinson’s Disease ,APD,Vol.2 No.2, 2013
Fulvio Lauretani Gian Paolo Ceda Augusto Scaglioni Anna Nardelli
Citations: 1(Details)

Low Frequency of Leisure-Time Activities Correlates with Cognitive Decline and Apathy in Patients with Parkinson’s Disease ,APD,Vol.3 No.3, 2014
Kayoko Miura Shutaro Takashima Mie Matsui Kortaro Tanaka
Citations: 1(Details)

Effects of Cholinesterase Inhibitors in Cognition on Parkinson’s Disease Dementia: A Systematic Review and Meta-Analysis ,APD,Vol.4 No.4, 2015
Marina Martorelli Larissa Monteiro Ailton Melo
Citations: 1(Details)

Inhibition of foxo and minibrain in Dopaminergic Neurons Can Model Aspects of Parkinson Disease in Drosophila melanogaster ,APD,Vol.5 No.1, 2016
Mahin S. Chavoshi Brian E. Staveley
Citations: 1(Details)

Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients ,APD,Vol.1 No.1, 2012
Rui Zhang Danielle C. Spengler Marie-Helene Saint-Hilaire Anna D. Hohler
Citations: 1(Details)

A Blueberry Extract Supplemented Diet Partially Restores α-Synuclein-Dependent Lifespan Loss and Developmental Defects in Drosophila ,APD,Vol.3 No.2, 2014
David B. Lipsett Brian E. Staveley
Citations: 1(Details)

Sleep Disturbance in Parkinson’s Disease Varies with Age of Onset and Family History ,APD,Vol.5 No.4, 2016
Divya Madhusudhan Daniella Sisniega Andrew Ferree Janice Weinberg Marie Saint-Hilaire Samuel Ellias Anna DePold Hohler
Citations: 1(Details)

Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions ,APD,Vol.6 No.1, 2017
Pamela Latino Stefania Tagliente Clelia Pellicano Morena Giovannelli Francesco E. Pontieri 1 1
Citations: 1(Details)

LDN-73794 Attenuated LRRK2-Induced Degeneration in a Drosophila Parkinson’s Disease Model ,APD,Vol.4 No.3, 2015
Dejun Yang 1 1 1 1 Sharmila Das Loujing Song Tianxia Li Jianqun Yan Wanli W. Smith
Citations: 1(Details)

Differences between Istradefylline Responders and Non-Responders in Parkinson’s Disease ,APD,Vol.6 No.2, 2017
Asako Yoritaka Nobutaka Hattori
Citations: 1(Details)

Clinical Experience with Generic Rasagiline (Ralago^®) in Patients with Parkinson’s Disease: An Open-Label, Multicenter, Observational Study ,APD,Vol.8 No.2, 2019
Dávid Pintér Júlia Lajtos József Janszky Norbert Kovács
Citations: 1(Details)